Gemtuzumab ozogamicin s Midostaurinem v intenzivní léčbě CD33/FLT3+ AML – aktualizovaná data.

• Title in English: Gemtuzumab ozogamicin with Midostaurin in the intensive treatment of CD33/FLT3+ AML - updated data
• Authors: WEINBERGEROVÁ Barbora; ČERŇAN M.; SZOTKOWSKI Tomáš; SEMERÁD Lukáš; KABUT T.; NAVRÁTILOVÁ J.; PODSTAVKOVÁ N.; PROCHÁZKOVÁ Jiřina; JEŽÍŠKOVÁ Ivana; KLEMEŠOVÁ Iveta; FOLTA A.; MAYER Jiří
• Year of publication: 2023
• Type: Conference abstract
• MU Faculty or unit: Faculty of Medicine
• Description: Gemtuzumab ozogamicin with Midostaurin in the intensive treatment of CD33/FLT3+ AML - updated data - conference abstract.

Related projects

• National institute for cancer research